Heron Therapeutics, Inc. · NASDAQ:HRTX

Duarte Ira exercised options for 12,500 Heron Therapeutics, Inc. shares (Form 4)

Traded Jun 16, 2026 · Filed Jun 17, 2026

On Jun 16, 2026, Duarte Ira (EVP, Chief Financial Officer) exercised options for 12,500 Heron Therapeutics, Inc. shares, leaving 261,073 shares. Filed Jun 17, 2026 (Form 4).

Options exercised
12,500 shares
Holding after
261,073 shares
Trading plan
No
Role
EVP, Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 16, 2026Common StockOption exercise12,500264,628Direct
Jun 16, 2026Common StockShares withheld for tax3,555US$0.38261,073Direct

Source

View original at SEC

Related